Product
  • Product
  • Content
  • No products in the cart.
Select Page
Hotline: 400-686-0075

As one of the major diseases threatening human health, tumor has always been in the spotlight of biomedical research. It is predicted that the number of deaths caused by cancer in 2030 will exceed 13.1 million. Recently, the research on cancer has also increased year by year, mainly covering genetic background, tumor immunity, viruses and tumors, hormones and tumors, cancer stem cells, angiogenesis and tumors, tumor suppressor genes, apoptosis and tumors, tumor microenvironment and epigenetics. Among them, tumor immunity and gene function mining, in particular, have provided new solutions for cancer treatment.

RiboBio provides TCGA bioinformatics analysis for biomedical scientists to fully accelerate the progress of cancer research. The analysis covers cancer-related mRNA, lncRNA and miRNA, and is the most characteristic service project of RiboBio.

Our Services

Categories Basic Analysis Advanced Analysis
mRNA Known mRNA Expression PFS Survivial Analysis of Differential mRNA
mRNA Difference Analysis Survival Analysis of Clinical Determinants
mRNA Differential Expression Clustering Patient Survival Model Prediction Based on mRNA Expression 
PCA Analysis
Survival Analysis of Differential mRNA  Prognostic Model for ROC Curve Evaluation
Single-factor CoxPH Analysis Prognostic Model for C-index Evaluation
OS Survival Curve Analysis and Mapping Expression Difference of Target Genes in Cancer and Adjacent Tissues
Prognosis-related Gene KEGG Pathway Enrichment Analysis Expression of Target Genes in Different Cancer Stage
Prognosis-related Gene GO Function Enrichment Analysis
lncRNA Known lncRNA Expression lncRNA-mRNA Co-expression Analysis
lncRNA Difference Analysis PFS Survival Analysis of Differential lncRNA
lncRNA Differential Expression Clustering Survival Analysis of Clinical Determinants
PCA Analysis Patient Survival Model Prediction Based on lncRNA Expression 
Survival Analysis of Differential lncRNA 
Single-factor CoxPH Analysis Prognostic Model for ROC Curve Evaluation
OS Survival Curve Analysis and Mapping Prognostic Model for C-index Evaluation
Prognosis-related lncRNA-target Gene Prediction Expression Difference of Target Genes in Cancer and Adjacent Tissues
Target Gene KEGG Pathway Enrichment Analysis Expression of Target Genes in Different Cancer Stage
Target Gene GO Function Enrichment Analysis
miRNA Known miRNA Expression PFS Survival Analysis of Differential miRNA
miRNA Difference Analysis Survival Analysis of Clinical Determinants
miRNA Differential Expression Clustering Patient Survival Model Prediction Based on miRNA Expression 
PCA Analysis Prognostic Model for ROC Curve Evaluation
Survival Analysis of Differential miRNA  Prognostic Model for C-index Evaluation
Single-factor CoxPH Analysis Construction of miRNA Regulatory Network
OS Survival Curve Analysis and Mapping Expression Difference of Target Genes in Cancer and Adjacent Tissues
Prognosis-related miRNA-target Gene Prediction Expression of Target Genes in Different Cancer Stage
Target Gene KEGG Pathway Enrichment Analysis
Target Gene GO Function Enrichment Analysis

Select Language:

Guangzhou RiboBio Co., Ltd.
Address:13-14/F, Innovation Building C3, 182 Kexue Avenue, Science Park, Guangzhou 510663, China
Service hotline:400-686-0075

Follow us

QQ
WeChat
Phone

Service hotline

400-686-0075


Message